Rabeprazole Extended Release 50 mg Versus Ranitidine 150 mg for Maintenance of Healed Erosive Gastroesophageal Reflux Disease (GERD)

This study has been completed.

Study NCT00839306 Information provided by Eisai Inc.

First Received: February 5, 2009 Last Updated: March 24, 2010 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2010
Primary Completion Date:	August 2009 (Final data collection date for primary outcome measure)